Skip to main content
. 2023 Sep 21;18(9):e0291024. doi: 10.1371/journal.pone.0291024

Fig 2. Correlations between CDCA2 expression and immune subtypes across TCGA tumors.

Fig 2

(A) ACC; (B) BLCA; (C) BRCA; (D) COAD; (E) ESCA; (F) KIRC; (G) KIRP; (H) LGG; (I) LIHC; (J) LUAD; (K) LUSC; (L) MESO; (M) OV; (N) PAAD; (O) PRAD; (P) READ; (Q) SARC; (R) SKCM; (S) STAD; (T) TGCT; (U) THCA; (V) UCEC.